Oncimmune Holdings Plc (ONC.L)

36.80 -1.25 (-3.29%) At close: 11:35AM GMT

Oncimmune Holdings Plc

MediCity
D6 Building 1 Thane Road
Nottingham NG90 6BH
United Kingdom
44 1157 840 500
https://www.oncimmune.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Adam Mark Hill Ph.D.	CEO & Director	439k	N/A	1980
Mr. Matthew Hall	Chief Financial Officer	N/A	N/A	N/A
Prof. Tariq Sethi M.D., B.Sc., M.A., Ph.D., FRCP	Chief Scientific Officer	N/A	N/A	N/A
Ms. Cléa Rosenfeld	Head of Investor Relations	N/A	N/A	N/A
Mr. Ron Kirschner	Gen. Counsel & Company Sec.	N/A	N/A	N/A
Dr. James R. Jett M.D.	Chief Medical Officer of US	N/A	N/A	N/A
Mr. Maarten Brusse	Chief Commercial Officer of Asia	N/A	N/A	N/A
Mr. Shane Smith	Sr. VP of Market Access & Reimbursement Oncimmune (Usa)	N/A	N/A	N/A
Mr. Cameron Barnard	Chief Bus. Officer	N/A	N/A	N/A
Mr. Daniel J. Calvo	Sr. Advisor	N/A	N/A	N/A

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Oncimmune Holdings plc develops and commercializes technologies that enable cancer diagnosis in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a immunodiagnostic test for detecting and identifying lung cancer. The company also develops SeroTag, a platform that is used to discover and validate biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel. Oncimmune Holdings plc has a collaboration with Siemens Healthineers AG. Oncimmune Holdings plc was incorporated in 2015 and is based in Nottingham, the United Kingdom.

Corporate governance

Oncimmune Holdings Plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.